Latest filing published 05 Jun 2025 for Aspira Women's Health Inc.. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
This profile gathers the share dealings of Stefanie L. Cavanaugh across 2 companies, led by Aspira Women's Health Inc. and Apollo Endosurgery, Inc. The record holds 9 filings, for trades running from 7 July 2021 to 4 June 2025.
Purchases make up the whole of the open-market record (1 purchase, €23k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 3 share grants and 4 option exercises.
On 5 June 2025 came the latest disclosure, an option exercise in Aspira Women's Health Inc. The last insider purchase was made public on 25 July 2023, 1,181 days ago. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations